Normalization of IFNAR1 and IFNAR2 levels in DS/CHD iPSCs decreased the activity of IFN signaling by decreasing p-STAT1 levels (Figure S5B) and rescued defects in cardiac differentiation by increasing cardiac gene expression (Figures S5B and S5C). The gene discussed is IFNAR2; the disease is Dravet syndrome.